DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Optimark (Gadoversetamide) - Hypotension - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypotension ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Optimark (Gadoversetamide) where reactions include hypotension. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Optimark side effects in female

Reported by a lawyer from United States on 2012-07-26

Patient: female, weighing 118.8 kg (261.4 pounds)

Reactions: Lymphadenopathy, Septic Encephalopathy, Tachycardia, Decubitus Ulcer, Upper Respiratory Tract Infection, Iron Deficiency Anaemia, Dermatitis, Graft Thrombosis, Oedema Peripheral, Pulmonary Oedema, Hyperphosphataemia, Hypertensive Heart Disease, Hypotension, Nephrogenic Systemic Fibrosis, Gene Mutation Identification Test Positive, Electrocardiogram QT Prolonged, Wheezing, Drug Interaction, Fall, Blood Bilirubin Decreased, Hyperparathyroidism, Erosive Oesophagitis, Graft Infection, Fluid Overload, Dyspnoea, Haemorrhoids, Syncope, Pericarditis, Sepsis, Sinus Disorder, Hypothyroidism, Asthma, Bronchopneumonia, Pleuritic Pain, Coagulopathy, Pulmonary Embolism, Cardiac Failure Acute, Duodenitis, Colon Adenoma, Nodule, Electrocardiogram T Wave Abnormal, Carpal Tunnel Syndrome, Abscess Limb, Pain in Extremity, Breast Calcifications, Respiratory Distress, Insomnia, Dyslipidaemia, Diverticulum Intestinal Haemorrhagic, Pain, Gastritis, Hypokalaemia, Myalgia, Neuropathy Peripheral, Pericardial RUB, Azotaemia, Gastrooesophageal Reflux Disease, Jugular Vein Thrombosis, Systemic Sclerosis, Tracheobronchitis, Migraine, Haemoptysis, Atrial Fibrillation, Renal Failure Chronic, Pneumonia Bacterial, Diarrhoea, Gastroenteritis, Protein C Deficiency, Hypertension, Superior Vena Cava Syndrome, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Optimark
    Dosage: 15 ml, single
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-08-31
    End date: 2005-08-31

Gadolinium
    Dosage: unk, single
    Indication: Angiogram
    Start date: 2004-02-06
    End date: 2004-02-06

Other drugs received by patient: Nephro-Vite / 01801401 /; Guaifenesin DM; Diovan; Renagel; Lorazepam; Accupril; Azithromycin; Tylenol with Codein #3; Propoxyphene HCL; Zosyn; Albuterol; Atenolol; Epogen; Calcitriol; Lasix; Atrovent; Hydralazine HCL



Possible Optimark side effects in female

Reported by a physician from United States on 2012-05-01

Patient: female

Reactions: Abdominal Pain, Orthostatic Hypotension, Pulmonary Embolism, Osteomyelitis, Headache, Ingrowing Nail, Staphylococcal Bacteraemia, Arteriosclerosis, Back Pain, Localised Infection, Pneumonia, Anaemia, Hypotension, Helicobacter Infection, Nephrogenic Systemic Fibrosis, Nail Hypertrophy, Osteopenia, Osteosclerosis, Iliac Artery Stenosis, Dehydration, Impaired Gastric Emptying, Spinal Column Stenosis, Pain, Fall, Hypoacusis, Skin Ulcer, Intervertebral Discitis, Chest Pain, Arteriovenous Fistula Thrombosis, Blood Pressure Increased, Vomiting, Nausea, Syncope, Diarrhoea, Sepsis, Retroperitoneal Lymphadenopathy, Spinal Osteoarthritis, Deep Vein Thrombosis, Infectious Peritonitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Optimark
    Dosage: unk, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-03
    End date: 2006-03-03

Multihance
    Dosage: 15 ml, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2008-07-30
    End date: 2008-07-30

Gadolinium
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2010-01-01
    End date: 2010-01-01

Optimark
    Indication: Angiogram

Omniscan
    Dosage: 40 ml, single
    Indication: Angiogram
    Start date: 2007-02-06
    End date: 2007-02-06

Multihance
    Dosage: 17 ml, single
    Start date: 2009-11-19
    End date: 2009-11-19



Possible Optimark side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-13

Patient: female

Reactions: Abdominal Pain, Osteomyelitis, Orthostatic Hypotension, Pulmonary Embolism, Headache, Ingrowing Nail, Staphylococcal Bacteraemia, Arteriosclerosis, Back Pain, Localised Infection, Pneumonia, Hypotension, Anaemia, Nail Hypertrophy, Helicobacter Infection, Nephrogenic Systemic Fibrosis, Dehydration, Impaired Gastric Emptying, Spinal Column Stenosis, Fall, Hypoacusis, Intervertebral Discitis, Skin Ulcer, Chest Pain, Arteriovenous Fistula Thrombosis, Blood Pressure Increased, Vomiting, Nausea, Syncope, Diarrhoea, Sepsis, Spinal Osteoarthritis, Deep Vein Thrombosis, Infectious Peritonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Multihance
    Dosage: 17 ml, single
    Start date: 2009-11-19
    End date: 2009-11-19

Optimark
    Dosage: unk, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-03
    End date: 2006-03-03

Optimark
    Indication: Angiogram

Omniscan
    Dosage: 40 ml, single
    Indication: Angiogram
    Start date: 2007-02-06
    End date: 2007-02-06

Multihance
    Dosage: 15 ml, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2008-07-30
    End date: 2008-07-30

Gadolinium
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2010-01-01
    End date: 2010-01-01

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012